4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-035342
Director sold 28,876 shares at an average $353.19 ($10,198,844)
- Director acquired 28,876 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FRIEDMAN PAUL A Director | 2025-07-16 | Option exercise 10b5-1 | +26,176 | $9.45 | $247,363 | 213,340 | D |
| FRIEDMAN PAUL A Director | 2025-07-16 | Sale 10b5-1 | −5,541 | $350.17 | $1,940,275 | 207,799 | D |
| FRIEDMAN PAUL A Director | 2025-07-16 | Sale 10b5-1 | −2,371 | $351.38 | $833,131 | 205,428 | D |
| FRIEDMAN PAUL A Director | 2025-07-16 | Sale 10b5-1 | −2,110 | $352.67 | $744,133 | 203,318 | D |
| FRIEDMAN PAUL A Director | 2025-07-16 | Sale 10b5-1 | −2,319 | $353.82 | $820,507 | 200,999 | D |
| FRIEDMAN PAUL A Director | 2025-07-16 | Sale 10b5-1 | −6,851 | $354.65 | $2,429,697 | 194,148 | D |
| FRIEDMAN PAUL A Director | 2025-07-16 | Sale 10b5-1 | −5,784 | $355.61 | $2,056,860 | 188,364 | D |
| FRIEDMAN PAUL A Director | 2025-07-16 | Sale 10b5-1 | −1,200 | $356.62 | $427,941 | 187,164 | D |
| FRIEDMAN PAUL A Director | 2025-07-17 | Option exercise 10b5-1 | +2,700 | $9.45 | $25,515 | 189,864 | D |
| FRIEDMAN PAUL A Director | 2025-07-17 | Sale 10b5-1 | −2,000 | $350.10 | $700,203 | 187,864 | D |
| FRIEDMAN PAUL A Director | 2025-07-17 | Sale 10b5-1 | −700 | $351.57 | $246,098 | 187,164 | D |
| Derivatives | |||||||
| FRIEDMAN PAUL A Director | 2025-07-16 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −26,176 | 180,080 | D | ||
| FRIEDMAN PAUL A Director | 2025-07-17 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,700 | 177,380 | D | ||
| Open-market sales · 28,876 sh · avg $353.19 · $10,198,844 | |||||||
Loading xslF345X05/wk-form4_1752869569.xml…